Clinical Trial Update: TACE Plus HAIC Combined With Regorafenib for Liver Metastasis of Colorectal Cancer Refractory to Standard Treatment Regimens [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of transarterial chemoembolization (TACE) and hepatic arterial infusion chemotherapy (HAIC) with Regorafenib f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Liver Metastasis

Drugs mentioned

• Regorafenib (regorafenib)

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Liver Metastasis Colon Cancer | Phase 2 | Status: COMPLETED